Penserra Capital Management LLC Atai Life Sciences N.V. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.03 - $5.32 $24,215 - $42,517	-7,992 Reduced 8.11%	90,581 $329,000
Q1 2022 May 13, 2022	BUY	$4.66 - $7.66 $272,111 - $447,290	58,393 Added 145.33%	98,573 $431,000
Q4 2021 Feb 15, 2022	BUY	$6.82 - $17.8 $52,118 - $136,027	7,642 Added 23.49%	40,180 $306,000
Q3 2021 Nov 15, 2021	BUY	$13.62 - $19.48 $443,167 - $633,840	32,538 New	32,538 $481,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.